What's breaking now, across thousands of outlets.
The Bridge program, which began July 1, makes some Medicare beneficiaries eligible for obesity drugs for $50 a month. CVS and Walgreens say they've each already filled 100,000 such prescriptions.
We haven't written up this one. NPR has the full story — the link below goes straight to it.
(MedPage Today) -- When the temperature heats up, so do emergency rooms, according to a massive study of Chicago hospital and urgent care records, which found increased accidental gunshot wounds…
Researchers have uncovered a biological mechanism that helps explain why hepatitis E virus infections can be especially severe—and often fatal—during pregnancy, finding that normal pregnancy-related…
Children with severe hearing loss may benefit from cochlear implants at younger ages and under broader eligibility criteria than previously recognized, according to a multicenter study led by…
The FDA approves Revolution Medicines’ Rasonque for metastatic pancreatic cancer after a trial showed the drug doubled survival for patients.
Researchers investigating the role of progranulin in cancer progression have previously identified the signaling receptor EphA2 as critical in tumor establishment and a potential target to enhance the…
When a cell gets ready to divide, it shuts down its gene-reading machinery almost entirely. For decades, the mechanism behind that shutdown was only partially understood.
